KR20250019788A - A hydrogel composition for removing skin keratin, and a patch comprising the same - Google Patents
A hydrogel composition for removing skin keratin, and a patch comprising the same Download PDFInfo
- Publication number
- KR20250019788A KR20250019788A KR1020230100801A KR20230100801A KR20250019788A KR 20250019788 A KR20250019788 A KR 20250019788A KR 1020230100801 A KR1020230100801 A KR 1020230100801A KR 20230100801 A KR20230100801 A KR 20230100801A KR 20250019788 A KR20250019788 A KR 20250019788A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogel composition
- acid
- exfoliation
- skin
- gelling agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 102000011782 Keratins Human genes 0.000 title abstract description 9
- 108010076876 Keratins Proteins 0.000 title abstract description 9
- 239000003349 gelling agent Substances 0.000 claims abstract description 41
- 238000004299 exfoliation Methods 0.000 claims abstract description 34
- 239000000679 carrageenan Substances 0.000 claims abstract description 30
- 229920001525 carrageenan Polymers 0.000 claims abstract description 30
- 229940113118 carrageenan Drugs 0.000 claims abstract description 30
- 229920001059 synthetic polymer Polymers 0.000 claims abstract description 25
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 24
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 24
- 229920005615 natural polymer Polymers 0.000 claims abstract description 17
- 239000004909 Moisturizer Substances 0.000 claims abstract description 11
- 230000001333 moisturizer Effects 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims description 24
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 claims description 22
- 210000004927 skin cell Anatomy 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 12
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 12
- 229960003681 gluconolactone Drugs 0.000 claims description 12
- 229940099563 lactobionic acid Drugs 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 11
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 7
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 6
- 235000011613 Pinus brutia Nutrition 0.000 claims description 6
- 241000018646 Pinus brutia Species 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- -1 polyvinylpyridone Polymers 0.000 claims description 6
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920002873 Polyethylenimine Polymers 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 3
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000004971 Cross linker Substances 0.000 claims description 2
- 241000972672 Phellodendron Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 45
- 239000003431 cross linking reagent Substances 0.000 abstract description 8
- 210000003491 skin Anatomy 0.000 description 49
- 206010040844 Skin exfoliation Diseases 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 13
- 210000000434 stratum corneum Anatomy 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920001273 Polyhydroxy acid Polymers 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000972673 Phellodendron amurense Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 229940061720 alpha hydroxy acid Drugs 0.000 description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 150000002402 hexoses Chemical class 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 210000001047 desmosome Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000030549 Claviceps gigantea Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 201000009058 cervical adenitis Diseases 0.000 description 1
- 208000012751 cervical lymphadenitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229940094332 peg-8 dimethicone Drugs 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000018192 pine bark supplement Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940106796 pycnogenol Drugs 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 210000000439 stratum lucidum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 수용성 하이드로겔이 가지지 못한 강력한 리프팅 효과를 가지며 각질을 흡착하여 불투명하게 변화하는 각질 제거용 하이드로겔 조성물에 관한 것으로, 가교제; 보습제; 아이오타 카라기난을 포함하는 천연고분자 겔화제; 및 합성고분자 겔화제;를 포함하는 각질 제거용 하이드로겔 조성물이 제공된다.The present invention relates to a hydrogel composition for exfoliation that has a strong lifting effect that water-soluble hydrogels do not have and that absorbs keratin and changes it to opaque, and provides a hydrogel composition for exfoliation that includes: a crosslinking agent; a moisturizer; a natural polymer gelling agent including iota carrageenan; and a synthetic polymer gelling agent.
Description
본 발명은 각질 흡착 하이드로겔 조성물에 관한 것으로, 피부에 부착했을 때 피부 온도에 의해 용해되어 유효성분의 경피 전달을 향상시키고, 각질뿐만 아니라 피지를 포함하는 불순물을 흡착하여 피부 리프팅 효과와 함께 피부 각질을 효과적으로 제거하는 하이드로겔 조성물에 관한 것이다.The present invention relates to a keratin-absorbing hydrogel composition, which, when attached to the skin, dissolves at skin temperature to enhance transdermal delivery of an active ingredient, and effectively removes keratin by absorbing impurities including sebum as well as keratin, thereby providing a skin-lifting effect.
불규칙적인 생활과 밤낮이 바뀌는 생활 패턴의 변화, 사회 생활에서 발생되는 스트레스와 환경 오염에 의한 외인적 요인과 연령 증가에 따른 자연적인 피부 노화 등의 원인으로 각질층의 수분이 감소하여 피부가 건조해지며 표면이 거칠어져 피부가 윤기를 잃어 칙칙하게 보이는 등의 현상이 나타난다.Due to external factors such as irregular lifestyle and changes in day and night cycle, stress from social life, environmental pollution, and natural skin aging due to aging, the moisture in the stratum corneum decreases, the skin becomes dry, the surface becomes rough, the skin loses its luster, and appears dull.
팩 제형의 화장품은 일시적으로 피부 위에 얇은 피막을 씌워 외부로의 수분 증발을 차단시켜 피부를 촉촉하게 하고 유효성분을 효과적으로 침투시키는 특성을 가진 제형으로서 최근 팩 제형의 화장품에 대한 관심이 증대되고 있다.Cosmetics in pack form temporarily form a thin film over the skin to block moisture evaporation to the outside, moisturizing the skin and allowing effective penetration of active ingredients. Recently, interest in cosmetics in pack form has been increasing.
마스크 팩은 피부 표면을 감싸 수분 및 미용 성분을 피부에 공급함으로써 피부 생리 기능을 회복시켜주는 제품이다.A mask pack is a product that restores the skin's physiological function by wrapping the skin surface and supplying moisture and beauty ingredients to the skin.
통상적으로 마스크 팩은 부직포로 구성된 시트층에 보습제, 미백제 등과 같은 피부 미용 성분을 함침시켜 제조되며, 피부 표면에 일정 시간 부착하여 함침된 피부 미용 성분이 피부에 효과적으로 흡수될 수 있도록 한다.Typically, mask packs are manufactured by impregnating skin beauty ingredients such as moisturizers and whitening agents into a sheet layer made of non-woven fabric, and then attaching it to the skin surface for a certain period of time to allow the impregnated skin beauty ingredients to be effectively absorbed into the skin.
한편, 피부는 크게 표피, 진피, 피하지방조직의 3개 층으로 구성된다. 표피(epidermis)는 바깥쪽에서 안쪽으로 각질층, 투명층, 과립층, 기저층으로 나뉜다. Meanwhile, the skin is largely composed of three layers: the epidermis, dermis, and subcutaneous fat tissue. The epidermis is divided from the outside to the inside into the stratum corneum, stratum lucidum, stratum granulosum, and stratum basale.
표피의 최외곽 층인 피부 각질층(stratum corneum)은 피부장벽 기능의 가장 중요한 구조로서, 무핵의 편평한 각질세포(corneocytes)와 각질세포간 지질(SC intercellular lipid)로 이루어져 있다. The stratum corneum, the outermost layer of the epidermis, is the most important structure for the skin barrier function and is composed of non-nucleated, flat keratinocytes (corneocytes) and intercellular lipids (SC).
정상적인 표피세포의 분열 및 분화과정을 통해 유지되는 피부장벽의 각질세포가 합성하는 세라마이드, 콜레스테롤, 및 지방산과 같은 세포간 지질로 형성된 다층지질막(multi lamella lipid layer)은 피부 내의 수분이 증발하지 않도록 방어막 역할을 한다.The multi-lamellar lipid layer formed by intercellular lipids such as ceramide, cholesterol, and fatty acids synthesized by keratinocytes of the skin barrier, which is maintained through the division and differentiation process of normal epidermal cells, acts as a protective barrier to prevent moisture within the skin from evaporating.
피부 각질층의 각질 세포는 데스모좀이라 불리우는 단백질에 의하여 연결되어 있으며, 각질층 상부로 올라갈수록 데스모좀은 분해되어 각질 세포간 응집력이 약화되고 최종적으로 각질 세포는 피부로부터 분리되어 떨어져 나간다.The keratinocytes in the stratum corneum are connected by proteins called desmosomes. As they move upward in the stratum corneum, the desmosomes break down, weakening the cohesion between keratinocytes and ultimately causing the keratinocytes to separate from the skin and fall off.
정상 피부의 경우 각질층은 15 내지 20층으로 구성되고 이들이 완전히 분리되는 데는 15 내지 20일이 소요된다. In normal skin, the stratum corneum consists of 15 to 20 layers, and it takes 15 to 20 days for them to completely separate.
그러나 나이가 들어감에 따라 피부 구성 성분인 표피, 진피 및 피하 조직의 두께가 얇아지고 피부의 수분 함량이 급격히 감소하며, 피부에 탄력을 주는 ECM(Extracellular Matrix) 성분의 변화로 인해 피부가 탄력을 잃고 주름이 지게 되며 각질층의 분리가 정상보다 늦어져 각질층이 두꺼워 지고(각질중층화) 피부가 활력을 잃게 된다.However, as we age, the epidermis, dermis, and subcutaneous tissues, which are the components of the skin, become thinner, the moisture content of the skin decreases rapidly, and the skin loses elasticity and wrinkles due to changes in the ECM (Extracellular Matrix) component that gives the skin elasticity. In addition, the separation of the stratum corneum becomes slower than normal, so the stratum corneum thickens (keratinization), and the skin loses vitality.
각질중층화는 주로 피부의 보습력 감소, 데스모좀 분해 효소의 생성 및 활성감소, 세포 활성 저하 등에 기인하며 피부노화, 자외선노출, 공해 등이 유발 요인이 된다. Keratin stratification is mainly caused by decreased moisturizing power of the skin, decreased production and activity of desmosome-decomposing enzymes, and decreased cell activity, and is triggered by skin aging, exposure to ultraviolet rays, and pollution.
이러한 내, 외적인 요인에 의해 두꺼워진 각질층을 외부에서 인위적으로 얇게 해주면 각질층 밑에 있는 살아있는 세포의 활성 혹은 재생이 증가되어 피부가 부드러워지며, 주름제거, 여드름 발생 억제 및 치료 등의 효과가 있어 자극이 유발되지 않는 범위 내에서 각질중층화를 해소하려는 연구가 많이 진행되고 있다.If the stratum corneum, which has thickened due to these internal and external factors, is artificially thinned externally, the activity or regeneration of living cells beneath the stratum corneum increases, making the skin smoother, and has the effects of removing wrinkles, suppressing and treating acne, etc. Therefore, many studies are being conducted to resolve stratum corneum within a range that does not cause irritation.
각질중충화를 해소하기 위해 피부를 물리적으로 문지르거나 화학적 박피술을 이용한다. Physically rubbing the skin or using chemical peeling techniques to remove dead skin cells.
화학적 박피는 잔주름 개선, 거친 피부 완화, 잡티제거 등의 부가적인 효과가 있다. 화학적 박피에 사용되는 물질은 기본적으로 AHA(Alpha-Hydroxy Acid)와 BHA(Beta-Hydroxy Acid)가 주로 사용되고 있다.Chemical peeling has additional effects such as improving fine wrinkles, softening rough skin, and removing blemishes. The substances used in chemical peeling are basically AHA (Alpha-Hydroxy Acid) and BHA (Beta-Hydroxy Acid).
그러나, AHA는 피부에 대한 자극이 너무 커서 각질 제거 용도로 사용하기에 적절치 않고, 폴리하이드록시애씨드(PHA)는 피부의 각질 세포의 이온결합 에너지를 낮추어 과각질을 제거하거나 각질화 과정의 주기를 짧게 하여 피부 세포의 활성을 촉진시켜 피부를 개선하는 효과를 지니고 있으나, 다량 사용시에 피부 자극을 유발하게 되는 단점을 지니고 있어 화장품 원료로서 사용이 제한되고 있다.However, AHA is too irritating to the skin and is not suitable for use as an exfoliator, and polyhydroxy acid (PHA) has the effect of improving the skin by lowering the ionic bonding energy of keratinocytes to remove dead skin cells or shortening the cycle of the keratinization process to promote skin cell activity. However, it has the disadvantage of causing skin irritation when used in large quantities, and so its use as a cosmetic ingredient is limited.
따라서, 피부에 대한 자극을 최소화하면서도 효과적으로 피부의 각질을 제거하기 위한 수단의 개발이 요구되는 시점이며, 본 발명자들은 화학적인 각질 제거제의 사용을 배제하거나 사용을 최소화하면서 효율적으로 각질을 제거할 수 있는 새로운 기능 및 방식의 마스크팩을 도출함으로써 본 발명을 완성하였다. Therefore, it is a time when the development of a means for effectively removing dead skin cells while minimizing irritation to the skin is required, and the inventors of the present invention have completed the present invention by deriving a mask pack with a new function and method that can efficiently remove dead skin cells while eliminating or minimizing the use of chemical exfoliants.
본 발명은 전술한 종래 기술의 문제점을 해결하기 위한 것으로, 본 발명의 목적은 피부에 대한 자극 없이 쉽게 사용할 수 있으면서도 피부 보습과 함께 리프팅 효과를 나타내면서도 피부 각질을 효과적으로 흡착할 수 있는 새로운 제형의 하이드로겔 조성물을 제공하는 것이다.The present invention is to solve the problems of the prior art described above, and the purpose of the present invention is to provide a new type of hydrogel composition that can be easily used without irritating the skin, while exhibiting a lifting effect along with moisturizing the skin, and effectively absorbing dead skin cells.
본 발명의 일 측면에 따르면, 가교제; 보습제; 아이오타 카라기난을 포함하는 천연고분자 겔화제; 및 합성고분자 겔화제;를 포함하는 각질 제거용 하이드로겔 조성물이 제공된다.According to one aspect of the present invention, a hydrogel composition for exfoliation is provided, comprising: a crosslinking agent; a moisturizer; a natural polymer gelling agent including iota carrageenan; and a synthetic polymer gelling agent.
일 실시예에 있어서, 상기 천연고분자 겔화제는 카파 카라기난 및 아이오타 카라기난으로 이루어진 것일 수 있다.In one embodiment, the natural polymer gelling agent may be comprised of kappa carrageenan and iota carrageenan.
일 실시예에 있어서, 상기 카파 카라기난 및 아이오타 카라기난은 100: 80 내지 120의 중량비로 이루어진 것일 수 있다.In one embodiment, the kappa carrageenan and iota carrageenan may be present in a weight ratio of 100:80 to 120.
일 실시예에 있어서, 상기 각질 제거용 하이드로겔 조성물은 락틱애씨드, 시트릭애씨드, 글라이콜릭애씨드, 글루코노락톤, 말릭애씨드, 타타릭애씨드, 살리실릭애씨드, 락토바이오닉애씨드, 카프릴로일살리실릭애씨드로 이루어진 군에서 선택된 하나 이상의 각질제거제;를 더 포함할 수 있다.In one embodiment, the hydrogel composition for exfoliation may further include one or more exfoliating agents selected from the group consisting of lactic acid, citric acid, glycolic acid, gluconolactone, malic acid, tartaric acid, salicylic acid, lactobionic acid, and capryloyl salicylic acid.
일 실시예에 있어서, 상기 각질제거제는 글루코노락톤 및 락토바이오닉애씨드로 이루어진 것일 수 있다.In one embodiment, the exfoliating agent may comprise gluconolactone and lactobionic acid.
일 실시예에 있어서, 상기 합성고분자 겔화제는 폴리리아크릴레이트 또는 그 염, 폴리메타크릴산, 카르복시비닐폴리머, 폴리비닐알코올, 폴리아크릴아미드, 폴리에틸렌옥시드, 폴리에틸렌이민, 폴리비닐피돌리돈, 피브이피, 메틸셀룰로오스, 셀룰로오스, 카르복시메틸셀룰로오스, 및 하이드록시 에텔셀룰로오스로 이루어진 군에서 선택된 하나 이상일 수 있다.In one embodiment, the synthetic polymer gelling agent may be at least one selected from the group consisting of polyacrylate or a salt thereof, polymethacrylic acid, carboxyvinyl polymer, polyvinyl alcohol, polyacrylamide, polyethylene oxide, polyethyleneimine, polyvinylpyridone, PVP, methylcellulose, cellulose, carboxymethylcellulose, and hydroxy ether cellulose.
일 실시예에 있어서, 상기 각질 제거용 하이드로겔 조성물은 상기 천연고분자 겔화제 100중량부; 및 상기 합성고분자 겔화제 50 내지 150중량부;를 포함할 수 있다.In one embodiment, the hydrogel composition for exfoliation may include 100 parts by weight of the natural polymer gelling agent; and 50 to 150 parts by weight of the synthetic polymer gelling agent.
일 실시예에 있어서, 상기 각질 제거용 하이드로겔 조성물은 솔잎 추출물, 마치현 추출물 및 황백 추출물로 이루어진 군에서 선택된 하나 이상의 천연 추출물을 더 포함할 수 있다. In one embodiment, the hydrogel composition for exfoliation may further comprise one or more natural extracts selected from the group consisting of pine needle extract, Machihyeon extract, and Phellodendron amurense extract.
본 발명에 따르면, 상기 하이드로겔 조성물은 우수한 점착력 및 수축력을 가져 피부에 안면 등 신체 소정의 부위에 부착 후 제거하는 것만으로도 피부 보습 및 리프팅 효과를 제공할 뿐만 아니라 피부 표면의 각질을 흡착하게 되므로 각질 제거 효과를 동시에 나타낼 수 있다.According to the present invention, the hydrogel composition has excellent adhesiveness and contractile force, so that it can provide skin moisturizing and lifting effects simply by attaching it to a certain part of the body, such as the face, and then removing it, and can also exhibit an exfoliation effect at the same time by absorbing dead skin cells on the skin surface.
상기 하이드로겔 조성물은 피부 밀착력이 우수하여 흘러내림이나 미끄러짐 없이 장시간 피부 부착이 가능하며, 동시에 에센스 용출량을 조절하여 보습감을 부여해 수분감 및 피부 진정효과를 줄 수 있다.The above hydrogel composition has excellent skin adhesion, so it can be attached to the skin for a long time without running down or slipping, and at the same time, it can provide a moisturizing feeling by controlling the amount of essence released, thereby providing a moisturizing feeling and skin soothing effect.
본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.It should be understood that the effects of the present invention are not limited to the effects described above, but include all effects that can be inferred from the composition of the invention described in the detailed description or claims of the present invention.
도 1은 본 발명의 일 실시예에 따른 각질 제거용 하이드로겔 조성물의 사용 전 후의 모습을 비교한 것이다. Figure 1 compares the appearance before and after use of a hydrogel composition for exfoliation according to one embodiment of the present invention.
본 명세서에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. The terms used in this specification have been selected from widely used general terms as much as possible while considering the functions in the present invention, but these may vary depending on the intention of engineers working in the field, precedents, the emergence of new technologies, etc.
또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.In addition, in certain cases, there are terms that the applicant has arbitrarily selected, and in this case, the meaning thereof will be described in detail in the description of the invention. Therefore, the terms used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than simply the name of the term.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다. Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Terms defined in commonly used dictionaries, such as those defined in common usage, should be interpreted as having a meaning consistent with the meaning they have in the context of the relevant art, and will not be interpreted in an idealized or overly formal sense unless expressly defined in this application.
수치 범위는 상기 범위에 정의된 수치를 포함한다. 본 명세서에 걸쳐 주어진 모든 최대의 수치 제한은 낮은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 낮은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 최소의 수치 제한은 더 높은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 높은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 수치 제한은 더 좁은 수치 제한이 명확히 쓰여져 있는 것처럼, 더 넓은 수치 범위 내의 더 좋은 모든 수치 범위를 포함할 것이다.The numerical ranges are inclusive of the numbers defined in the above ranges. Every maximum numerical limitation given throughout this specification will include every lower numerical limitation, as if that lower numerical limitation were expressly written out. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if that higher numerical limitation were expressly written out. Every numerical limitation given throughout this specification will include every better numerical range within that broader numerical range, as if that narrower numerical limitation were expressly written out.
이하, 본 발명의 실시예를 상세히 기술하나, 하기 실시예에 의해 본 발명이 한정되지 아니함은 자명하다.Hereinafter, examples of the present invention will be described in detail, but it is obvious that the present invention is not limited to the following examples.
본 발명의 일 측면에 따르면, 가교제; 보습제; 아이오타 카라기난을 포함하는 천연고분자 겔화제; 및 합성고분자 겔화제;를 포함하는 각질 제거용 하이드로겔 조성물이 제공된다.According to one aspect of the present invention, a hydrogel composition for exfoliation is provided, comprising: a crosslinking agent; a moisturizer; a natural polymer gelling agent including iota carrageenan; and a synthetic polymer gelling agent.
상기 하이드로겔 조성물은 친수성 고분자(Hydrophilic Polymer)의 사슬이 가교(crosslinking)를 이루어 3차원 망상구조(Treedimensional Network)를 형성한 것으로 물을 함유하면서 물에 용해되지 않는 고분자 재료일 수 있고, 본 발명에 따른 하이드로겔 조성물은 불용성의 합성 고분자를 포함하는 하이브리드 형태의 겔로서 하이드로겔의 부착성을 개선하여 피부에 밀착될 수 있다.The above hydrogel composition may be a polymer material that contains water but does not dissolve in water, in which chains of a hydrophilic polymer are crosslinked to form a three-dimensional network structure, and the hydrogel composition according to the present invention is a hybrid gel containing an insoluble synthetic polymer, and improves the adhesiveness of the hydrogel so that it can adhere to the skin.
도 1을 참조하면, 상기 하이드로겔 조성물은 수용성 하이드로겔이 가지지 못한 강력한 점착력 및 리프팅 효과를 나타내며 사용 전 투명한 형태이나 안면에 부착 후 일정 시간 경과하면 피부의 각질을 흡착하여 불투명하게 변화할 수 있다.Referring to Fig. 1, the hydrogel composition exhibits strong adhesiveness and lifting effect that water-soluble hydrogels do not have, and is transparent before use, but after being attached to the face, it may change to opaque after a certain period of time by absorbing keratin of the skin.
상기 하이드로겔 조성물은 각질을 포함한 다양한 불순물을 흡착하여 사용 후 유백색으로 변하게 되는 시각적인 효과를 제공하므로, 각질 제거 용도로서 유용하게 활용될 수 있다.The above hydrogel composition can be usefully utilized for exfoliation purposes because it provides a visual effect of changing to a milky white color after use by adsorbing various impurities including keratin.
특히, 상기 하이드로겔 조성물은 높은 탄성 및 강도를 보유하고 있어 소정의 패드 형상으로 가공되어 특정 신체 부위에 부착시켜 간편하게 사용할 수 있다.In particular, the hydrogel composition has high elasticity and strength, so it can be processed into a predetermined pad shape and attached to a specific body part for convenient use.
이를 위해, 상기 각질 제거용 하이드로겔 조성물은 가교제; 보습제; 아이오타 카라기난을 포함하는 천연고분자 겔화제; 및 합성고분자 겔화제;를 포함할 수 있다.To this end, the hydrogel composition for exfoliation may include a crosslinking agent; a moisturizer; a natural polymer gelling agent including iota carrageenan; and a synthetic polymer gelling agent.
상기 가교제는 곧은 사슬모양 중합체 혹은 분기 중합체에 교차결합을 형성하기 위해 사용되는 것으로 다가 금속염인 것이 바람직하며, 예컨대, 알루미늄글리시네이트, 수산화알루미늄, 수산화알루미늄겔, 함수규산알루미늄, 카올린, 아세트산알루미늄, 락트산알루미늄, 스테아르산알루미늄, 염화캄슘, 염화마그네슘, 염화알루미늄, 젖산칼슘, 염화칼륨, 메타규산알루민산마그네슘, 및 규산알루민산마그네슘으로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.The crosslinking agent is preferably a polyvalent metal salt used to form a crosslink in a straight chain polymer or a branched polymer, and may be, for example, at least one selected from the group consisting of aluminum glycinate, aluminum hydroxide, aluminum hydroxide gel, hydrous aluminum silicate, kaolin, aluminum acetate, aluminum lactate, aluminum stearate, calcium chloride, magnesium chloride, aluminum chloride, calcium lactate, potassium chloride, magnesium aluminometasilicate, and magnesium aluminosilicate, but is not limited thereto.
상기 보습제는 피부 보습 효과를 제공하고 피부 표면에 수분을 공급하여 각질이 효과적으로 흡착될 수 있도록 하는 것으로 다가 알코올인 것이 바람직하며, 예컨대, 글리세린, 에틸렌글리콜, 1,3-부틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 소르비톨, 및 자일리톨로 구성되는 그룹 으로부터 선택되는 1종 이상일 수 있으나, 이에 제한되는 것은 아니다.The above moisturizer is preferably a polyhydric alcohol that provides a skin moisturizing effect and supplies moisture to the skin surface so that dead skin cells can be effectively absorbed, and may be, for example, at least one selected from the group consisting of glycerin, ethylene glycol, 1,3-butylene glycol, propylene glycol, dipropylene glycol, sorbitol, and xylitol, but is not limited thereto.
상기 천연고분자 겔화제는 하이드로겔의 골격을 이루도록 하는 것으로, 예컨대, 카라기난, 한천, 캐롭검, 잔탄검, 젤란검, 알진, 글루코만난, 갈락토만난, 구아검, 플루로닉으로 이루어진 군으로부터 선택된 하나 이상일 수 있으며, 아이오타 카라기난을 포함할 수 있다.The above natural polymer gelling agent forms the skeleton of the hydrogel and may be, for example, at least one selected from the group consisting of carrageenan, agar, carob gum, xanthan gum, gellan gum, algin, glucomannan, galactomannan, guar gum, and pluronic, and may include iota-carrageenan.
상기 카라기난(carrageenan)은 해조(chondrus crispus)에서 유래하는 물질로 그 구조는 α-1,3 혹은 β결합의 헥소오스를 갖는 3,6-안하이드로스-D-갈락토오스(3,6-anhydrous-D-galactose)와 D-갈락토오스의 칼륨, 나트륨, 마그네슘, 칼슘, 황산암모늄 에스테르의 공중합체로, 헥소오스 구조의 황산기의 위치와 수에 따라 아이오타(iota), 카파(kappa), 람다(lambda)로 나눌 수 있다. The above carrageenan is a substance derived from seaweed ( Chondrus crispus ) and its structure is a copolymer of 3,6-anhydrous-D-galactose with α-1,3 or β-bonded hexose and potassium, sodium, magnesium, calcium, and ammonium sulfate esters of D-galactose. Depending on the position and number of sulfate groups in the hexose structure, it can be divided into iota, kappa, and lambda.
상기 아이오타 카라기난은 헥소오스의 2번 위치에 황산기를 갖고 있고, 카파 카라기난은 각각의 이당단위에 한개의 황산기를 갖고 있으며, 분자량은 10 내지 35 kDa을 나타낸다. The above iota carrageenan has a sulfate group at position 2 of the hexose, and kappa carrageenan has one sulfate group for each disaccharide unit, and has a molecular weight of 10 to 35 kDa.
상기 아이오타 카라기난은 칼슘 이온이있는 상태에서 부드러운 젤을 형성하며, 겔이 약하지만 수축 및 수분 이탈 현상이 적으며, 냉동과 해동에서 안정적인 특성이 있다.The above iota-carrageenan forms a soft gel in the presence of calcium ions, and although the gel is weak, it has little shrinkage and moisture loss, and is stable during freezing and thawing.
상기 아이오타 카라기난은 전분류, 단백질과 셀룰로오스 유도체와 작용해서 성질의 변화를 초래할 수 있으며, 상기 각질 제거용 하이드로겔 조성물에 시각적인 각질 제거 효과를 부여할 수 있다.The above iota-carrageenan can react with starch, protein and cellulose derivatives to cause changes in properties, and can impart a visual exfoliating effect to the above hydrogel composition for exfoliation.
이 때, 상기 천연고분자 겔화제는 카파 카라기난 및 아이오타 카라기난으로 이루어진 것일 수 있다.At this time, the natural polymer gelling agent may be composed of kappa carrageenan and iota carrageenan.
상기 카파 카라기난(Kappa Carrageenan)은 다른 종류의 카라기난에 비해 제형으로서의 제작이 쉽고 단단한 겔을 형성할 수 있다.The above kappa carrageenan is easier to produce as a formulation than other types of carrageenan and can form a firm gel.
상기 아이오타 카라기난은 단독으로 사용되었을 경우 카파 카라기난보다 조직이 덜 치밀하게 형성되므로 겔이 약한 문제점이 있으나, 상기 카파 카라기난과 혼합할 경우 시너지 효과를 얻을 수 있어 이수 현상이 방지되고, 높은 강도 및 탄력을 가지는 겔을 형성할 수 있다.The above iota carrageenan, when used alone, forms a less dense texture than kappa carrageenan, which causes a weak gel; however, when mixed with the above kappa carrageenan, a synergistic effect can be obtained, preventing the water-loss phenomenon and forming a gel with high strength and elasticity.
일 실시예에서, 상기 카파 카라기난 및 아이오타 카라기난은 100: 80 내지 120의 중량비로 이루어진 것일 수 있다.In one embodiment, the kappa carrageenan and iota carrageenan may be present in a weight ratio of 100:80 to 120.
상기 카파 카라기난 및 아이오타 카라기난을 혼합하여 소정의 물성을 구현할 수 있고, 각질을 포함한 피부 표면의 불순물을 제거하기 위한 용도로서 사용될 수 있으나, 상기 카파 카라기난 및 아이오타 카라기난의 혼합 비율이 상기 범위를 벗어나는 경우 의도하는 기술적 효과가 적절히 구현되지 않을 수 있다.The above kappa carrageenan and iota carrageenan can be mixed to implement a desired physical property and can be used for the purpose of removing impurities on the skin surface including dead skin cells. However, if the mixing ratio of the kappa carrageenan and iota carrageenan is outside the above range, the intended technical effect may not be properly implemented.
구체적으로, 상기 아이오타 카라기난의 함량이 과소하면(100 : 80 미만이면) 겔이 약해져 탄력이 저하되고 이수 현상이 심화될 수 있는 반면, 과다하면(100 : 120 초과이면) 강도가 높아져 쉽게 깨지거나 수분감이 저하될 수 있다.Specifically, if the content of the iota-carrageenan is too low (less than 100:80), the gel may become weak, lose elasticity, and experience aggravated water loss, whereas if the content is too high (more than 100:120), the strength may increase, making it easy to break or reducing moisture content.
한편, 상기 합성고분자 겔화제는 점착성 및 탄성을 부여하여 사용성을 개선하기 위한 것으로, 상기 카파 카라기난 및 아이오타 카라기난과 함께 도입되어 하이드로겔에 점착성을 제공하며 효율적으로 각질 등의 피부 표면 불순물이 흡착되도록 할 수 있다.Meanwhile, the synthetic polymer gelling agent is introduced together with the kappa carrageenan and iota carrageenan to provide adhesiveness to the hydrogel and to efficiently adsorb skin surface impurities such as keratin.
상기 합성고분자 겔화제는 인공적인 결합을 통해 사슬과 그물 모양으로 만들어진 큰 분자를 지칭하는 것으로, 예컨대, 폴리아크릴레이트 또는 그 염, 폴리메타크릴산, 카르복시비닐폴리머, 폴리비닐알코올, 폴리아크릴아미드, 폴리에틸렌옥시드, 폴리에틸렌이민, 폴리비닐피돌리돈, 피브이피, 메틸셀룰로오스, 셀룰로오스, 카르복시메틸셀룰로오스, 및 하이드록시 에텔셀룰로오스로 이루어진 군에서 선택된 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.The above synthetic polymer gelling agent refers to a large molecule formed into a chain and mesh shape through artificial bonding, and may be, for example, at least one selected from the group consisting of polyacrylate or a salt thereof, polymethacrylic acid, carboxyvinyl polymer, polyvinyl alcohol, polyacrylamide, polyethylene oxide, polyethyleneimine, polyvinylpyridolidone, PVP, methylcellulose, cellulose, carboxymethylcellulose, and hydroxy ether cellulose, but is not limited thereto.
한편, 상기 각질 제거용 하이드로겔 조성물은 상기 천연고분자 겔화제 및 상기 합성고분자 겔화제의 작용을 통해 피부 각질을 효과적으로 흡착할 수 있으며, 더욱 효율적으로 피부 각질을 제거하기 위해 소량의 각질제거제를 포함할 수 있다.Meanwhile, the hydrogel composition for removing dead skin cells can effectively adsorb dead skin cells through the action of the natural polymer gelling agent and the synthetic polymer gelling agent, and may include a small amount of an exfoliating agent to remove dead skin cells more efficiently.
상기 각질제거제는 락틱애씨드, 시트릭애씨드, 글라이콜릭애씨드, 글루코노락톤, 말릭애씨드, 타타릭애씨드, 살리실릭애씨드, 락토바이오닉애씨드, 카프릴로일살리실릭애씨드로 이루어진 군에서 하나 이상 선택될 수 있으나 이에 제한되는 것은 아니며, 각 성분의 특성을 고려하여 각질제거제를 적절하게 선택할 수 있다. The above exfoliating agent may be selected from the group consisting of, but not limited to, one or more of lactic acid, citric acid, glycolic acid, gluconolactone, malic acid, tartaric acid, salicylic acid, lactobionic acid, and capryloyl salicylic acid, and the exfoliating agent may be appropriately selected by considering the characteristics of each ingredient.
상기 각질제거제는 각질 제거 효과가 있음에도 불구하고 피부 자극으로 인해 사용이 제한될 수 있는데, 상기 각질 제거용 하이드로겔 조성물은 상기 각질제거제를 소량 포함하는 경우에도, 상기 겔의 흡착 특성으로 인해 각질 제거 효율이 극대화될 수 있다.Although the above exfoliating agent has an exfoliating effect, its use may be limited due to skin irritation. However, the hydrogel composition for exfoliation can maximize the exfoliating efficiency due to the adsorption properties of the gel even when it contains a small amount of the exfoliating agent.
상기 각질 제거용 하이드로겔 조성물은 총 중량 대비 상기 각질제거제를 0.1 내지 0.5 중량% 함유할 수 있다.The above hydrogel composition for exfoliation may contain 0.1 to 0.5 wt% of the exfoliating agent relative to the total weight.
상기 각질제거제 함량이 0.1 중량% 미만이면 각질제거제 도입에 따른 효과가 충분히 구현되지 않을 수 있고, 0.5 중량% 초과이면 피부 자극으로 인해 사용성이 저하될 수 있다. If the content of the exfoliating agent is less than 0.1 wt%, the effect of introducing the exfoliating agent may not be sufficiently realized, and if it exceeds 0.5 wt%, the usability may be reduced due to skin irritation.
일 실시예에서, 상기 각질제거제는 글루코노락톤 및 락토바이오닉애씨드로 이루어진 것일 수 있다.In one embodiment, the exfoliating agent may comprise gluconolactone and lactobionic acid.
상기 글루코노락톤은 PHA(Poly Hydroxy Acid)로서 수용성 각질제거 성분 중 하나이며, 상기 글루코노락톤은 분자 구조가 크기 때문에 피부에 빠르게 침투하지 못해 상대적으로 적은 자극도를 가지고 있어 각질을 부드럽게 제거하여 고운 피부결로 관리하는데 도움을 주고 민감한 피부에 효과적으로 수분 보습력을 증대시켜 피부 방어막 역할의 컨디셔닝 효과를 준다.The above gluconolactone is a PHA (Poly Hydroxy Acid) and is one of the water-soluble exfoliating ingredients. Since the gluconolactone has a large molecular structure, it does not penetrate the skin quickly and thus has relatively little irritation, so it gently removes dead skin cells and helps maintain a smooth skin texture. It also effectively increases moisture retention for sensitive skin and provides a conditioning effect that acts as a skin barrier.
상기 락토바이오닉애씨드는 수분 보유력이 뛰어나고 토스(유당)의 산화로 만들어진 락토바이오닉애씨드는 상처 치유에 도움이 되기도 하며, 피부 결을 개선해주고, 모공 관리, 진정 효과, 각질 제거 효과를 나타낼 수 있다.The above-mentioned lactobionic acid has excellent moisture retention capacity, and lactobionic acid, which is created by the oxidation of lactose (milk sugar), helps with wound healing, improves skin texture, and can have pore management, soothing, and exfoliating effects.
상기 각질 제거용 하이드로겔 조성물은 글루코노락톤 및 락토바이오닉애씨드와 함께 작용하여 피부 자극은 최소화면서도 피부 보습 및 각질 제거 효과는 극대화될 수 있다.The above hydrogel composition for exfoliation works together with gluconolactone and lactobionic acid to minimize skin irritation while maximizing skin moisturizing and exfoliation effects.
상기 각질 제거용 하이드로겔 조성물은 상기 천연고분자 겔화제 100중량부; 및 상기 합성고분자 겔화제 50 내지 150중량부;를 포함할 수 있다.The hydrogel composition for removing dead skin cells may include 100 parts by weight of the natural polymer gelling agent; and 50 to 150 parts by weight of the synthetic polymer gelling agent.
상기 각질 제거용 하이드로겔 조성물은 상기 천연고분자 겔화제 및 상기 합성고분자 겔화제를 포함하여 우수한 점착성 및 사용성이 구현될 수 있으며, 피부 각질을 제거하기 위한 용도로서 사용될 수 있으나, 상기 천연고분자 겔화제 및 상기 합성고분자 겔화제의 혼합 비율이 상기 범위를 벗어나는 경우 의도하는 기술적 효과가 적절히 구현되지 않을 수 있다.The above hydrogel composition for removing dead skin cells can realize excellent adhesiveness and usability by including the natural polymer gelling agent and the synthetic polymer gelling agent, and can be used for the purpose of removing dead skin cells. However, if the mixing ratio of the natural polymer gelling agent and the synthetic polymer gelling agent is outside the above range, the intended technical effect may not be properly realized.
구체적으로, 상기 합성고분자 겔화제의 함량이 과소하면(100 : 50 미만이면) 점착성이 저하되어 각질 흡착 효과가 미흡할 수 있고, 과다하면(100 : 150 초과이면) 수분감이 저하되고 과도한 점착성으로 인해 피부 자극이 증가될 수 있다.Specifically, if the content of the synthetic polymer gelling agent is too low (less than 100:50), the adhesiveness may be reduced and the keratin adsorption effect may be insufficient, and if it is too high (more than 100:150), the moisture content may be reduced and skin irritation may increase due to excessive adhesiveness.
상기 각질 제거용 하이드로겔 조성물은 솔잎 추출물, 마치현 추출물 및 황백 추출물로 이루어진 군에서 선택된 하나 이상의 천연 추출물을 더 포함할 수 있다. The above hydrogel composition for exfoliation may further include one or more natural extracts selected from the group consisting of pine needle extract, Machihyeon extract, and Phellodendron amurense extract.
상기 각질 제거용 하이드로겔 조성물은 피부 각질 제거 효과를 증진시키고, 피부 자극을 최소화하기 위한 천연 추출물을 더 포함할 수 있고, 이를 통해 피부 보습, 주름 개선 등 다양한 효과를 동시에 구현할 수 있다.The above hydrogel composition for exfoliation may further include a natural extract to enhance the effect of exfoliation and minimize skin irritation, thereby simultaneously achieving various effects such as skin moisturizing and wrinkle improvement.
상기 솔잎은 소나무의 잎으로 솔잎에 포함된 아피에긴산, 테르펜, 피크노제놀, 비타민 C 등의 성분이 니코틴을 배출 및 해독하며, 항염, 항균작용, 항산화작용, 빈혈개선, 혈관성질환 예방, 피로해소, 면역력 개선, 위장 질환 예방 등에 도움을 주는 것으로 알려져 있다.The pine needles mentioned above are the leaves of a pine tree, and the apieugic acid, terpene, pycnogenol, vitamin C, and other components contained in the pine needles are known to help expel and detoxify nicotine, and have anti-inflammation, antibacterial, antioxidant effects, improve anemia, prevent vascular diseases, relieve fatigue, improve immunity, and prevent gastrointestinal diseases.
상기 마치현은 쇠비름과의 쇠비름(Portulaca oleracea L.)의 전초를 말한다. 상기 마치현은 잎 모양이 말의 이빨과 비슷하게 생겼고 약재의 성질이 매끄러운 것이 비름과 유사하기 때문에 생긴 이름이다. 상기 마치현은 해열, 해독, 지혈효과가 있어 세균성 이질, 종기, 치질, 경부림프절염, 습진, 대하, 자궁출혈, 소변불리 등에 사용한다. 약리작용으로 항균작용, 자궁평활근 수축력 증강으로 인한 장관 연동작용, 이뇨작용 등이 보고된 바 있다.The above-mentioned Machihyeon refers to the whole plant of Portulaca oleracea L. of the Purslane family. The above-mentioned Machihyeon is named because the shape of the leaf resembles a horse's tooth and the smooth nature of the medicinal herb is similar to that of Amaranth. The above-mentioned Machihyeon has antipyretic, detoxifying, and hemostatic effects, so it is used for bacterial dysentery, boils, hemorrhoids, cervical lymphadenitis, eczema, diarrhea, uterine bleeding, and urinary incontinence. Its pharmacological effects have been reported to include antibacterial effects, intestinal peristalsis due to increased uterine smooth muscle contractility, and diuretic effects.
상기 “황백”은 운향과(Rutaceae)에 속하는 황벽나무의 껍질을 말린 것으로, 혈압강하 작용, 혈액응고 촉진 작용을 하는 것으로 알려져 있다.The above “Hwangbaek” is the dried bark of the Phellodendron amurense tree, which belongs to the Rutaceae family, and is known to have blood pressure-lowering and blood clotting-promoting effects.
상기 “추출물”은 당업계에서 조추출물(crude extract)로 통용되는 의미를 갖지만, 광의적으로는 추출물을 추가적으로 분획(fractionation)한 분획물도 포함한다. 즉, 상기 추출물은 추출 용매를 이용하여 얻은 것뿐만 아니라, 여기에 정제과정을 추가적으로 적용하여 얻은 것도 포함한다. The above “extract” has the meaning commonly used in the art as a crude extract, but in a broad sense also includes a fraction obtained by further fractionating an extract. That is, the above extract includes not only one obtained by using an extraction solvent, but also one obtained by additionally applying a purification process thereto.
예컨대, 상기 추출물을 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 통과시켜 얻은 분획, 다양한 크로마토그래피(크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 포함될 수 있다.For example, fractions obtained by passing the extract through an ultrafiltration membrane having a predetermined molecular weight cut-off value, fractions obtained by various additional purification methods such as separation by various chromatographies (designed for separation by size, charge, hydrophobicity or affinity), etc. may also be included.
본 발명의 각질 제거용 하이드로겔 조성물은 필요에 따라 pH 조절제, 보존제, 향료, 계면활성제, 피부유효성분 등과 같은 부가 성분을 더 포함할 수 있으며, 상기 부가 성분의 종류는 특별히 제한되는 것은 아니다.The hydrogel composition for exfoliation of the present invention may further include additional ingredients such as a pH regulator, a preservative, a fragrance, a surfactant, and skin-effective ingredients, as needed, and the types of the additional ingredients are not particularly limited.
상기 pH 조절제는 주석산, 우레아, 암모니아, 암모늄포스페이트, 디에탄올아민, 디메틸에탄올아민, 소듐바이카보네이트, 소듐하이드로젤카보네이트, 트리에틸아민, 트리에탄올아민, 폴리에틸렌이민, 칼슘하이드록사이드, 포타슘하이드록사이드, 글리시리진산, 아스코르빈산, 살리실산, 스테아린산, 아미노산, 아젤레익산, 트로메타민, 알지닌, 아시아틱산, 및 옥살산으로 이루어진 군으로부터 하나 이상 선택될 수 있으나 이에 제한되는 것은 아니다.The above pH adjusting agent may be selected from the group consisting of, but is not limited to, one or more of tartaric acid, urea, ammonia, ammonium phosphate, diethanolamine, dimethylethanolamine, sodium bicarbonate, sodium hydrocarbonate, triethylamine, triethanolamine, polyethyleneimine, calcium hydroxide, potassium hydroxide, glycyrrhizic acid, ascorbic acid, salicylic acid, stearic acid, amino acids, azelaic acid, tromethamine, arginine, asiatic acid, and oxalic acid.
상기 보존제는 카프릴글라이콜, 파라옥시벤조산알킬에스테르, 벤조산, 벤조산나트륨, 소르빈산, 소르빈산칼륨, 페녹시에탄올, 파라벤, 펜탄디올, 안식향산, 살리실산, 디하이드로초산 또는 그 염류, 에틸헥실글리세린, 1,2-헥산디올, 카프릴글리콜트로포론, p-옥시안식향산 에스테르, 3-트리플루오로메틸-4,4'-디클로로카바바닐라이드, 및 2,4,4'-트리클로로-2-하이드록시디페닐에테르로 이루어진 군에서 하나 이상 선택될 수 있으나, 이에 제한되는 것은 아니다.The above preservative may be at least one selected from the group consisting of capryl glycol, p-hydroxybenzoic acid alkyl ester, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, phenoxyethanol, paraben, pentanediol, benzoic acid, salicylic acid, dihydroacetic acid or a salt thereof, ethylhexylglycerin, 1,2-hexanediol, capryl glycol trophorone, p-oxybenzoic acid ester, 3-trifluoromethyl-4,4'-dichlorocarbavanilide, and 2,4,4'-trichloro-2-hydroxydiphenyl ether, but is not limited thereto.
상기 계면활성제는 글리세릴 모노스테아레이트, 폴리글리세릴-4이소스테아레이트, 솔비탄모노스테아레이트 및 슈가 에스텔·모노스테아레이트를 포함하는 다가알콜; 지방산의 에스텔계 피이지-8 디메치콘, 피이지-10 디메치콘, 피이지-9 메틸에테르디메치콘, 피이지-3 디메치콘 및 피이지-11 메틸에테르디메티콘을 포함하는 폴리옥시에틸렌메틸폴리실록산공중합체; 피이지/피피지-20/20 부틸에테르디메치콘 및 피이지/피피지20/20 디메치콘을 포함하는 폴리(옥시에틸렌·옥시프로필렌)메틸폴리실록산 공중합제; 및 세틸피이지/피피지10/1-디메치콘 및 라우릴 피이지-9 폴리디메칠실록시에틸디메치콘을 포함하는 알킬 사슬·실리콘 사슬 분기형 폴리(옥시에틸렌·옥시프로필렌)메틸폴리실록산 공중합제로 이루어진 군에서 선택된 하나 이상일 수 있으나 이에 제한되는 것은 아니다.The above surfactants are polyhydric alcohols including glyceryl monostearate, polyglyceryl-4 isostearate, sorbitan monostearate, and sugar ester monostearate; polyoxyethylene methylpolysiloxane copolymers including fatty acid esters such as PEG-8 dimethicone, PEG-10 dimethicone, PEG-9 methyl ether dimethicone, PEG-3 dimethicone, and PEG-11 methyl ether dimethicone; poly(oxyethylene-oxypropylene) methylpolysiloxane copolymers including PEG/PPG-20/20 butyl ether dimethicone and PEG/PPG 20/20 dimethicone; and cetyl PEG/PPG10/1-dimethicone and lauryl PEG-9 polydimethylsiloxyethyl dimethicone. The copolymer may be at least one selected from the group consisting of alkyl chain·silicone chain branched poly(oxyethylene·oxypropylene) methylpolysiloxane copolymers, but is not limited thereto.
상기 있는 피부유효성분은 예컨대, 알부틴, 나이아신아마이드, 비타민 C, 비타민 B5, 비타민 E, 레티놀, 코엔자임큐텐, 아데노신 및 천연 추출물로 구성되는 그룹으로부터 선택되는 1종 이상일 수 있으나, 이에 제한되는 것은 아니다.The above skin effective ingredients may be at least one selected from the group consisting of, for example, arbutin, niacinamide, vitamin C, vitamin B5, vitamin E, retinol, coenzyme Q10, adenosine, and natural extracts, but are not limited thereto.
상기 각질 제거용 하이드로겔 조성물은 다양한 형태, 크기, 및 두께로 제조할 수 있고 안면 등 신체 부위에 쉽게 탈부착 하는 방식으로 사용할 수 있으며, 예컨대, 0.5 내지 5.0 mm 두께로 제조할 수 있으나, 이에 제한되는 것은 아니다.The above hydrogel composition for exfoliation can be manufactured in various shapes, sizes, and thicknesses and can be used in a manner that it can be easily attached and detached to a body part such as the face. For example, it can be manufactured to have a thickness of 0.5 to 5.0 mm, but is not limited thereto.
상기 하이드로겔 조성물이 0.5 mm 미만이면 쉽게 찢어지는 등 사용성이 일부 저하될 수 있고, 5.0 mm 초과이면 제조 비용이 증가되거나 중량감으로 인해 신체 부위에 부착시 사용감이 저하될 수 있다.If the above hydrogel composition is less than 0.5 mm, its usability may be reduced to some extent, such as being easily torn, and if it exceeds 5.0 mm, its manufacturing cost may increase or its usability may be reduced when attached to a body part due to its weight.
이하 실시예를 통해, 본 발명을 더욱 상술하나 하기 실시예에 의해 본 발명이 제한되지 아니함은 자명하다.The present invention is further described through the following examples, but it is obvious that the present invention is not limited by the following examples.
제조예Manufacturing example
하기 표 1 및 2에 제시된 성분들을 사용하여 실시예 및 비교예의 하이드로겔을 제조하였다.Hydrogels of examples and comparative examples were prepared using the ingredients presented in Tables 1 and 2 below.
보습제, 가교제 및 용매 성분을 60 내지 80℃의 온도에 서 혼합한 후, 천연고분자 겔화제, 합성고분자 겔화제, 및 기타 나머지 첨가제 성분들을 첨가하고 혼합하여 하이드로겔 혼합물을 수득하였다.After mixing the moisturizer, crosslinker, and solvent components at a temperature of 60 to 80°C, the natural polymer gelling agent, synthetic polymer gelling agent, and other remaining additive components were added and mixed to obtain a hydrogel mixture.
이를 필름상에 코팅한 후 소정의 형태로 성형하여 하이드로겔을 수득하였다.This was coated on a film and then molded into a desired shape to obtain a hydrogel.
하이드로겔 제조에 있어서, 보습제는 글리세린, 가교제는 알루미늄글리시네이트를 사용하였다. In the production of hydrogel, glycerin was used as a moisturizer and aluminum glycinate was used as a crosslinking agent.
천연고분자 겔화제는 아이오타 카라기난, 카파 카라기난, 한천, 글루코만난, 잔탄검 중 하나 이상을 사용하였고, 합성고분자 겔화제는 소듐폴리아크릴레이트를 사용하였다.The natural polymer gelling agent used was at least one of iota carrageenan, kappa carrageenan, agar, glucomannan, and xanthan gum, and the synthetic polymer gelling agent used was sodium polyacrylate.
실시예 및 비교예의 경우 각 성분의 유무 또는 조성비를 일부 달리함으로써 각 성분에 따른 차이를 살펴보고자 하였다.In the examples and comparative examples, the differences in each component were examined by changing the presence or absence of each component or the composition ratio.
실험예 : 품질 평가Experimental example: Quality assessment
물성 평가는 5점 척도법으로 평균을 산출하여 결정하였다. 하이드로겔 조성물의 리프팅 효과, 피부유연화 효과, 각질제거 효과 등의 실험 결과값을 숫자 1(나쁨) 내지 5(좋음)로 적용하였고 결과 값을 표 3에 표시하였다.The physical property evaluation was determined by calculating the average using a 5-point scale. The experimental results of the lifting effect, skin softening effect, and exfoliation effect of the hydrogel composition were applied as numbers 1 (bad) to 5 (good), and the result values are shown in Table 3.
표 3을 참조하면, 아이오타 카라기난 및 카파 카라기난 중 하나 이상을 포함하고, 합성고분자 겔화제를 포함하는 실시예 1 내지 8은 아이오타 카라기난 및 카파 카라기난을 포함하지 않는 비교예 1 내지 4 대비 리프팅 효과, 피부 유연화 효과, 각질제거 효과가 현저히 높은 수준으로 평가되었다.Referring to Table 3, Examples 1 to 8 including at least one of iota-carrageenan and kappa-carrageenan and including a synthetic polymer gelling agent were evaluated to have significantly higher levels of lifting effect, skin softening effect, and exfoliation effect compared to Comparative Examples 1 to 4 not including iota-carrageenan and kappa-carrageenan.
또한, 비교예 5 및 6의 경우 아이오타 카라기난 및 카파 카라기난을 모두 포함하고 있으나, 합성고분자 겔화제의 함량이 과소 또는 과다한 경우 전체적인 품질이 일부 저하되는 모습을 나타내었다.In addition, in the case of Comparative Examples 5 and 6, although both iota carrageenan and kappa carrageenan were included, the overall quality was shown to be somewhat deteriorated when the content of the synthetic polymer gelling agent was insufficient or excessive.
비교예 7의 경우 아이오타 카라기난 및 카파 카라기난을 모두 포함하고 있으나, 합성고분자 겔화제를 포함하지 않으므로, 각질 제거 효과 등 본원발명이 의도하는 기술적 효과가 구현되지 않았다.In the case of Comparative Example 7, although both iota carrageenan and kappa carrageenan were included, since a synthetic polymer gelling agent was not included, the technical effects intended by the present invention, such as the exfoliation effect, were not realized.
실시예 1 및 3의 경우 카파 카라기난을 포함하지 않으므로 리프팅 효과 등 품질이 상대적으로 낮은 수준으로 평가되었으나, 일정 수준 이상의 품질을 나타내었다.In the case of Examples 1 and 3, since kappa carrageenan was not included, the quality, such as the lifting effect, was evaluated to be relatively low, but a certain level of quality was shown.
실시예 6의 경우 실시예 4의 락틱애씨드를 글루코노락톤 및 락토바이오닉애씨드로 대체함으로써 피부 유연화 효과 및 각질 제거 효과가 다소 개선되는 모습을 보였으므로, 품질 개선을 위해 각질제거제 성분을 달리할 수 있다.In the case of Example 6, the skin softening effect and exfoliation effect were somewhat improved by replacing the lactic acid of Example 4 with gluconolactone and lactobionic acid, so the exfoliating agent component can be changed to improve quality.
실시예 7 및 8의 경우 실시예 4 대비 일부 천연 추출물을 투입하였으며, 피부 유연화 효과 및 각질 제거 효과가 더욱 개선되는 모습을 보였으므로, 상기 천연 추출물이 본 발명의 하이드로겔 성분과 상승 효과를 나타낼 수 있음을 확인하였다.In examples 7 and 8, some natural extracts were added compared to example 4, and the skin softening effect and exfoliation effect were further improved, confirming that the natural extracts can exhibit a synergistic effect with the hydrogel component of the present invention.
상기 결과는 본 발명의 하이드로겔 조성물은 아이오타 카라기난, 카파 카라기난, 합성고분자 겔화제의 조합을 통해 피부 각질 제거 효과를 나타낼 수 있으며, 이 중 일부를 포함하지 않는다면 각질 제거 효과가 적절하게 구현되지 않음을 시사한다. The above results suggest that the hydrogel composition of the present invention can exhibit a skin exfoliation effect through a combination of iota-carrageenan, kappa-carrageenan, and a synthetic polymer gelling agent, and that the exfoliation effect is not properly implemented if some of these are not included.
또한, 본 발명의 하이드로겔 조성물의 각질제거제를 달리하거나, 시너지 작용을 나타내는 천연 추출물을 부가함으로써 더욱 우수한 품질의 하이드로겔을 제조할 수 있다. In addition, a hydrogel of even better quality can be produced by changing the exfoliating agent of the hydrogel composition of the present invention or adding a natural extract showing a synergistic effect.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustrative purposes, and those skilled in the art will understand that the present invention can be easily modified into other specific forms without changing the technical idea or essential characteristics of the present invention. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive. For example, each component described as a single component may be implemented in a distributed manner, and likewise, components described as distributed may be implemented in a combined form.
본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the claims set forth below, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention.
Claims (8)
보습제;
아이오타 카라기난을 포함하는 천연고분자 겔화제; 및
합성고분자 겔화제;를 포함하는 각질 제거용 하이드로겔 조성물.crosslinker;
moisturizer;
Natural polymer gelling agent comprising iota carrageenan; and
A hydrogel composition for exfoliation comprising a synthetic polymer gelling agent.
상기 천연고분자 겔화제는 카파 카라기난 및 아이오타 카라기난으로 이루어진 것인, 각질 제거용 하이드로겔 조성물.In the first paragraph,
A hydrogel composition for exfoliation, wherein the natural polymer gelling agent is composed of kappa carrageenan and iota carrageenan.
상기 카파 카라기난 및 아이오타 카라기난은 100: 80 내지 120의 중량비로 이루어진 것인, 각질 제거용 하이드로겔 조성물.In the second paragraph,
A hydrogel composition for exfoliation, wherein the above kappa carrageenan and iota carrageenan are comprised in a weight ratio of 100:80 to 120.
락틱애씨드, 시트릭애씨드, 글라이콜릭애씨드, 글루코노락톤, 말릭애씨드, 타타릭애씨드, 살리실릭애씨드, 락토바이오닉애씨드, 카프릴로일살리실릭애씨드로 이루어진 군에서 선택된 하나 이상의 각질제거제;를 더 포함하는, 각질 제거용 하이드로겔 조성물.In the first paragraph,
A hydrogel composition for exfoliation, further comprising at least one exfoliating agent selected from the group consisting of lactic acid, citric acid, glycolic acid, gluconolactone, malic acid, tartaric acid, salicylic acid, lactobionic acid, and capryloyl salicylic acid.
상기 각질제거제는 글루코노락톤 및 락토바이오닉애씨드로 이루어진 것인, 각질 제거용 하이드로겔 조성물.In paragraph 4,
A hydrogel composition for exfoliation, wherein the exfoliating agent comprises gluconolactone and lactobionic acid.
상기 합성고분자 겔화제는 폴리리아크릴레이트 또는 그 염, 폴리메타크릴산, 카르복시비닐폴리머, 폴리비닐알코올, 폴리아크릴아미드, 폴리에틸렌옥시드, 폴리에틸렌이민, 폴리비닐피돌리돈, 피브이피, 메틸셀룰로오스, 셀룰로오스, 카르복시메틸셀룰로오스, 및 하이드록시 에텔셀룰로오스로 이루어진 군에서 선택된 하나 이상인, 각질 제거용 하이드로겔 조성물.In the first paragraph,
A hydrogel composition for removing dead skin cells, wherein the synthetic polymer gelling agent is at least one selected from the group consisting of polyacrylate or a salt thereof, polymethacrylic acid, carboxyvinyl polymer, polyvinyl alcohol, polyacrylamide, polyethylene oxide, polyethyleneimine, polyvinylpyridone, PVP, methylcellulose, cellulose, carboxymethylcellulose, and hydroxy ether cellulose.
상기 천연고분자 겔화제 100중량부; 및 상기 합성고분자 겔화제 50 내지 150중량부;를 포함하는, 각질 제거용 하이드로겔 조성물.In Article 6,
A hydrogel composition for exfoliation, comprising 100 parts by weight of the natural polymer gelling agent; and 50 to 150 parts by weight of the synthetic polymer gelling agent.
솔잎 추출물, 마치현 추출물 및 황백 추출물로 이루어진 군에서 선택된 하나 이상의 천연 추출물을 더 포함하는, 각질 제거용 하이드로겔 조성물.
In paragraph 4,
A hydrogel composition for exfoliation, further comprising at least one natural extract selected from the group consisting of pine needle extract, machihyeon extract, and phellodendron extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230100801A KR20250019788A (en) | 2023-08-02 | 2023-08-02 | A hydrogel composition for removing skin keratin, and a patch comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230100801A KR20250019788A (en) | 2023-08-02 | 2023-08-02 | A hydrogel composition for removing skin keratin, and a patch comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20250019788A true KR20250019788A (en) | 2025-02-11 |
Family
ID=94613979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230100801A Pending KR20250019788A (en) | 2023-08-02 | 2023-08-02 | A hydrogel composition for removing skin keratin, and a patch comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20250019788A (en) |
-
2023
- 2023-08-02 KR KR1020230100801A patent/KR20250019788A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105194719B (en) | A kind of facial wound repairs dressing, application and preparation method thereof | |
US8071106B2 (en) | Topical formulation containing latex of fraction thereof, and cosmetic treatment method | |
KR101895038B1 (en) | Dissolvable film comprising spicule and use thereof | |
CN108686255B (en) | Biological dressing for preventing scar formation and preparation method thereof | |
KR102613845B1 (en) | Cosmetic composition for improvement of skin derived from natural products | |
KR101895037B1 (en) | Hydrogel comprising spicule and use thereof | |
CN117503663B (en) | Skin barrier repair composition, skin care product containing composition and preparation method of skin barrier repair composition | |
CN114159369A (en) | Anti-wrinkle repair essence mask containing bluecopper peptides | |
CN105749333B (en) | A kind of hyaluronic acid medical dressing and preparation method thereof | |
CN107929094A (en) | A kind of stoste and its preparation process | |
RU2383341C2 (en) | Method of skin rejuvenation | |
CN111643722A (en) | Sodium hyaluronate application containing icodextrin | |
CN109222534A (en) | A kind of pillowcase | |
KR20250019788A (en) | A hydrogel composition for removing skin keratin, and a patch comprising the same | |
KR101917026B1 (en) | Cosmetic composition for skin wrinkle improvement and prevention | |
KR102046331B1 (en) | Cosmetics or pharmaceutical composition containing magnolol or hinokiflavone for skin volume augmentation and anti-wrinkle | |
CN114222570A (en) | Skin care kit | |
KR101127190B1 (en) | Cosmetic composition containing medical plant feeling powder | |
KR101612463B1 (en) | Patch for softening keratinous substrates | |
CN105169463B (en) | A kind of cation baby's medical dressing and preparation method thereof | |
CN115024997A (en) | Cosmetic composition with skin aging resisting effect | |
CN105012990A (en) | Ultra-thin soft poly silicone scar removing paste and making method | |
CN112402311A (en) | Moisturizing body lotion and preparation method thereof | |
RU70792U1 (en) | MEDICAL APPLICATOR | |
CN111249177A (en) | Sterile repairing mask and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20230802 |
|
PA0201 | Request for examination |
Patent event code: PA02011R01I Patent event date: 20230802 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20250207 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application |